Logo
SearchSearch
Languages
Language
LoginSign up
Login
Invest in Mineralys Therapeutics Inc
Today
Create an eToro account to buy MLYS stock on a secure, user-friendly, multi-asset trading platform.
Buy Mineralys Therapeutics Inc
Buy Mineralys Therapeutics Inc
Mineralys Therapeutics Inc MLYS
Buy MLYS
Analyst Forecast
i
This 12-month forecast is based on a composite of analyst projections. Based on analysts with a rating of 4+ stars. This is not a prediction made by eToro nor is it investment advice.
Consensus
Moderate Buy
Price Target
29.5
Based on analysts who covered MLYS

Trending stocks

See stocks with the biggest daily volume spikes vs. their 3-month average.
Stocks-MLYS-Mineralys Therapeutics Inc

Mineralys Therapeutics Inc MLYS

$13.450.3(2.28%)(1D)
• Nasdaq • in USD

MLYS Stock Price Chart

‎28.65‎
Past Month
1D
1W
1M
6M
1Y
3Y
MAX
Sign up for full charts powered byTradingView logo
*Past performance is not an indication of future results
Asset positive trend

The Mineralys Therapeutics Inc share price is rising this week.

i
A ‘rising’ price indicates that the weekly price has increased by more than 0.5%.
A price ‘on the decline’ indicates that the weekly price has decreased by more than 0.5%.
A ‘stable’ price indicates that the change in weekly price is between -0.5% and 0.5%.
The Mineralys Therapeutics Inc share price today is $13.45, reflecting a ‎2.28‎% change over the last 24 hours and ‎32.58‎% over the past week. The current market capitalization of MLYS is 672.78M with an average volume in the last three months of 697348.19. The stock has a P/E ratio of -3.71 and a dividend yield of 0%. With the stock’s beta sitting at 0
Market Cap
i
Total value of all asset shares, calculated by multiplying the price by the total number of outstanding shares.
$672.78M
Day’s Range
i
Shows the high and low prices of the day.
8.23 - 18.22
52W Range
i
Shows the high and low prices of the last year.
8.23 - 18.22
Average Volume (3M)
i
The average number of shares traded per day over the last three months.
697348.19
Price-Earnings Ratio
i
The result of this asset’s share price divided by its earnings per share.
-3.71
Revenue
i
The total income generated by this company’s goods and services last year.
$0
Dividend (Yield)
i
How much a company pays out in dividends each year relative to its stock price.
0 (0%)
Prev Close
i
The final price of this asset at the end of the last trading day.
$13.5
EPS
i
A company’s total earnings divided by the number of shares it has issued.
-3.64
Beta
i
A measure of whether any asset does, or doesn’t, experience price moves in line with the broader market.
0
What Is Mineralys Therapeutics Inc?
Mineralys Therapeutics Inc is a clinical-stage biotechnology company that is engaged in the development of novel therapies for patients with hypertension, Chronic Kidney Disease (CKD) and other related diseases.

Operating in the biopharmaceutical sector, Mineralys’ primary focus is designing safe and effective medications to combat conditions linked to excess aldosterone. Its primary candidate is lorundrostat, a proprietary, orally administered, highly selective aldosterone synthase inhibitor (ASI).

Stay up to date on the share price of MLYS by adding it to your eToro watchlist.
Buy MLYS

How can I buy Mineralys Therapeutics Inc stocks?

To purchase Mineralys Therapeutics Inc:
01

Create an eToro account:

Sign up for an eToro account and verify your identity.
02

Deposit funds:

Deposit funds into your eToro account using your preferred payment method.
03

Search and purchase:

Search the Mineralys Therapeutics Inc (MLYS) page and place an order to buy Mineralys Therapeutics Inc.
Buy MLYS
Looking for more information? Check out our guide on Academy.
Top Guides
Our top picks for the most relevant guides from the eToro Academy
Top Dividend Stocks for 2025
Top Dividend Stocks for 2025
Gear up for 2025 with these top dividend stocks. Dive into the potential of Verizon, Exxon Mobil, NextEra, Coca Cola, Unicredit through eToro’s expert analysis.
Read More
Stock Trading And Investing For Beginners
Stock Trading And Investing For Beginners
New to online trading? Learn the basics with eToro. What are stocks? trading vs. investing, what are the risks, and how to open a trade, step by step.
Read More
AI Stocks Poised for Growth in 2025
AI Stocks Poised for Growth in 2025
Gear up for 2025 with AI stocks. Dive into the potential of Nvidia, Broadcom, CrowdStrike, Arista Networks, and Amphenol, through eToro’s expert analysis.
Read More
Go to the Academy >
Graph
Buy Mineralys Therapeutics Inc
Invest in Mineralys Therapeutics Inc
Today
Create an eToro account to buy MLYS stock on a secure, user-friendly, multi-asset trading platform.
Buy MLYS

FAQ

The current price of MLYS is $13.45.
The average price target for Mineralys Therapeutics Inc is $13.45. Sign up to eToro for detailed analyst forecasts and price targets.
Analysts offer forecasts for Mineralys Therapeutics Inc based on market trends, financial reports and projected growth. Check the latest forecast for future price movements.
The market capitalisation of Mineralys Therapeutics Inc is $672.78M
Daily Movers
Explore the biggest stocks movers on the market.
Buy MLYS
Scroll to top